Cilamac 250mg/250mg Injection
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Imipenem (250mg) + Cilastatin (250mg)
Overview Cilamac 250mg/250mg Injection
Combiflox 250 mg/250 mg Injection, a dual-antibiotic formulation, targets severe bacterial infections. Its mechanism combats infectious agents, thus curbing further infection spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed schedule is crucial, completing the entire treatment regardless of symptom improvement. Typical side effects encompass nausea, vomiting, diarrhea, and skin rashes; localized injection site reactions like redness, swelling, and discomfort may also occur, usually resolving spontaneously. Escalating side effects necessitate immediate consultation. Allergic reactions (skin rashes, itching, swelling, respiratory distress) demand urgent medical attention. Prior to commencement, inform your doctor of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior physician approval. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occur.
Uses of Cilamac 250mg/250mg Injection
Life-threatening bacterial infestations
Major Benefits of Cilamac 250mg/250mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cilamac 250mg/250mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Cilamac 250mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Cilamac 250mg/250mg Injection works:
Cilamac Injection, containing 250 mg each of imipenem and cilastatin, utilizes a dual-drug approach to combat bacterial infection. Imipenem, a potent antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Cilastatin, an inhibitor of dehydropeptidase I, prevents the enzymatic degradation of imipenem, thereby extending its therapeutic efficacy within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of consuming alcohol while receiving Cilamac 250 mg/250 mg Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Cilamac 250 mg/250 mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of Cilamac 250 mg/250 mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant harm from the medication.
DrivingUNSAFE
Administering Cilamac 250 mg/250 mg Injection may induce adverse reactions impacting driving capabilities. Certain side effects, including hallucinations (visual, auditory, or sensory), can impair some patients' ability to operate a vehicle.
KidneyCAUTION
For individuals with impaired kidney function, administering Cilamac 250 mg/250 mg Injection requires careful consideration. Dosage modification of Cilamac 250 mg/250 mg Injection might be necessary. A physician's consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Cilamac 250 mg/250 mg Injection to individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Cilamac 250mg/250mg Injection :
Omit a Cilamac 250 mg/250 mg Injection dose? Seek your physician's advice.
Facts to Know About Cilamac 250mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently